401k Plan data: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN plan

LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 401k Plan overview

Plan Name	LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN
Plan identification number	001

LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

AMERICAN REGENT, INC. has sponsored the creation of one or more 401k plans.

Company Name: AMERICAN REGENT, INC.

Employer identification number (EIN): 112695700

NAIC Classification: 325410

Additional information about AMERICAN REGENT, INC.

Jurisdiction of Incorporation: New York Department of State

Incorporation Date: 1946-04-02

Company Identification Number: 58306

Legal Registered Office Address: 5 Ramsey Road
5 RAMSEY ROAD
Shirley
United States of America (USA)
11967

More information about AMERICAN REGENT, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01 DEBRA CARLIN 2020-10-01 DEBRA CARLIN 2020-10-01
001 2018-01-01 DEBRA CARLIN 2019-10-15 DEBRA CARLIN 2019-10-15
001 2017-01-01
001 2016-01-01
001 2015-01-01
001 2014-01-01
001 2013-01-01
001 2012-01-01 DEBRA CARLIN DEBRA CARLIN 2013-09-18
001 2011-01-01 DEBRA CARLIN DEBRA CARLIN 2012-09-25
001 2010-01-01 DEBRA CARLIN DEBRA CARLIN 2011-09-29
001 2009-01-01 KAREN WISEMAN KAREN WISEMAN 2010-10-12

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01	DEBRA CARLIN	2020-10-01	DEBRA CARLIN	2020-10-01
001	2018-01-01	DEBRA CARLIN	2019-10-15	DEBRA CARLIN	2019-10-15
001	2017-01-01
001	2016-01-01
001	2015-01-01
001	2014-01-01
001	2013-01-01
001	2012-01-01	DEBRA CARLIN		DEBRA CARLIN	2013-09-18
001	2011-01-01	DEBRA CARLIN		DEBRA CARLIN	2012-09-25
001	2010-01-01	DEBRA CARLIN		DEBRA CARLIN	2011-09-29
001	2009-01-01	KAREN WISEMAN		KAREN WISEMAN	2010-10-12

Plan Statistics for LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN

401k plan membership statisitcs for LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN

Measure Date Value
2022: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 1,538
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 1,251
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 422
Total of all active and inactive participants 2022-01-01 1,673
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 2
Total participants 2022-01-01 1,675
Number of participants with account balances 2022-01-01 1,633
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 1
2021: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,532
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 1,095
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 422
Total of all active and inactive participants 2021-01-01 1,517
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 2
Total participants 2021-01-01 1,519
Number of participants with account balances 2021-01-01 1,490
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 3
2020: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 1,459
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 1,115
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 388
Total of all active and inactive participants 2020-01-01 1,503
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 2
Total participants 2020-01-01 1,505
Number of participants with account balances 2020-01-01 1,471
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 12
2019: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 1,431
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 1,045
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 414
Total of all active and inactive participants 2019-01-01 1,459
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 1,459
Number of participants with account balances 2019-01-01 1,453
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 132
2018: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 1,127
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 1,042
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 380
Total of all active and inactive participants 2018-01-01 1,422
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 1
Total participants 2018-01-01 1,423
Number of participants with account balances 2018-01-01 1,413
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 116
2017: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 1,028
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 833
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 290
Total of all active and inactive participants 2017-01-01 1,123
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 1
Total participants 2017-01-01 1,124
Number of participants with account balances 2017-01-01 1,117
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 107
2016: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 989
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 736
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 255
Total of all active and inactive participants 2016-01-01 991
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 1
Total participants 2016-01-01 992
Number of participants with account balances 2016-01-01 992
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 78
2015: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 872
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 656
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 249
Total of all active and inactive participants 2015-01-01 905
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 3
Total participants 2015-01-01 908
Number of participants with account balances 2015-01-01 902
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 82
2014: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 839
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 584
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 224
Total of all active and inactive participants 2014-01-01 808
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 808
Number of participants with account balances 2014-01-01 806
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 119
2013: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 778
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 559
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 198
Total of all active and inactive participants 2013-01-01 757
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 2
Total participants 2013-01-01 759
Number of participants with account balances 2013-01-01 756
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 60
2012: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 724
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 474
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 254
Total of all active and inactive participants 2012-01-01 728
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 2
Total participants 2012-01-01 730
Number of participants with account balances 2012-01-01 729
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 80
2011: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 523
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 604
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 83
Total of all active and inactive participants 2011-01-01 687
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 687
Number of participants with account balances 2011-01-01 687
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 36
2010: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 391
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 316
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 58
Total of all active and inactive participants 2010-01-01 374
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 1
Total participants 2010-01-01 375
Number of participants with account balances 2010-01-01 375
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 17
2009: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 375
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 297
Number of retired or separated participants receiving benefits 2009-01-01 12
Number of other retired or separated participants entitled to future benefits 2009-01-01 73
Total of all active and inactive participants 2009-01-01 382
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 382
Number of participants with account balances 2009-01-01 382
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 36

Measure	Date	Value
2022: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	1,538
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	1,251
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	422
Total of all active and inactive participants	2022-01-01	1,673
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	2
Total participants	2022-01-01	1,675
Number of participants with account balances	2022-01-01	1,633
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	1
2021: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,532
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	1,095
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	422
Total of all active and inactive participants	2021-01-01	1,517
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	2
Total participants	2021-01-01	1,519
Number of participants with account balances	2021-01-01	1,490
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	3
2020: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	1,459
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	1,115
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	388
Total of all active and inactive participants	2020-01-01	1,503
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	2
Total participants	2020-01-01	1,505
Number of participants with account balances	2020-01-01	1,471
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	12
2019: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	1,431
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	1,045
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	414
Total of all active and inactive participants	2019-01-01	1,459
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	1,459
Number of participants with account balances	2019-01-01	1,453
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	132
2018: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	1,127
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	1,042
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	380
Total of all active and inactive participants	2018-01-01	1,422
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	1
Total participants	2018-01-01	1,423
Number of participants with account balances	2018-01-01	1,413
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	116
2017: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	1,028
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	833
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	290
Total of all active and inactive participants	2017-01-01	1,123
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	1
Total participants	2017-01-01	1,124
Number of participants with account balances	2017-01-01	1,117
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	107
2016: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	989
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	736
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	255
Total of all active and inactive participants	2016-01-01	991
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	1
Total participants	2016-01-01	992
Number of participants with account balances	2016-01-01	992
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	78
2015: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	872
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	656
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	249
Total of all active and inactive participants	2015-01-01	905
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	3
Total participants	2015-01-01	908
Number of participants with account balances	2015-01-01	902
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	82
2014: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	839
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	584
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	224
Total of all active and inactive participants	2014-01-01	808
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	808
Number of participants with account balances	2014-01-01	806
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	119
2013: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	778
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	559
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	198
Total of all active and inactive participants	2013-01-01	757
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	2
Total participants	2013-01-01	759
Number of participants with account balances	2013-01-01	756
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	60
2012: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	724
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	474
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	254
Total of all active and inactive participants	2012-01-01	728
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	2
Total participants	2012-01-01	730
Number of participants with account balances	2012-01-01	729
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	80
2011: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	523
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	604
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	83
Total of all active and inactive participants	2011-01-01	687
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	687
Number of participants with account balances	2011-01-01	687
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	36
2010: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	391
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	316
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	58
Total of all active and inactive participants	2010-01-01	374
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	1
Total participants	2010-01-01	375
Number of participants with account balances	2010-01-01	375
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	17
2009: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	375
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	297
Number of retired or separated participants receiving benefits	2009-01-01	12
Number of other retired or separated participants entitled to future benefits	2009-01-01	73
Total of all active and inactive participants	2009-01-01	382
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	382
Number of participants with account balances	2009-01-01	382
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	36

Financial Data on LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN

Measure	Date	Value
2022 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-7,940,062
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$11,466,525
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$11,222,345
Expenses. Certain deemed distributions of participant loans	2022-12-31	$12,103
Value of total corrective distributions	2022-12-31	$6,846
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$24,501,199
Value of total assets at end of year	2022-12-31	$169,981,670
Value of total assets at beginning of year	2022-12-31	$189,388,257
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$225,231
Total interest from all sources	2022-12-31	$99,939
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$399,003
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$399,003
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$9,863,378
Participant contributions at end of year	2022-12-31	$2,479,455
Participant contributions at beginning of year	2022-12-31	$1,983,731
Participant contributions at end of year	2022-12-31	$289,570
Participant contributions at beginning of year	2022-12-31	$215,993
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$3,651,435
Other income not declared elsewhere	2022-12-31	$84
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-19,406,587
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$169,981,670
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$189,388,257
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$38,621,601
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$50,411,979
Value of interest in pooled separate accounts at end of year	2022-12-31	$20,752,852
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$23,489,020
Interest on participant loans	2022-12-31	$99,939
Value of interest in common/collective trusts at end of year	2022-12-31	$102,764,654
Value of interest in common/collective trusts at beginning of year	2022-12-31	$109,809,618
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-13,043,586
Net investment gain/loss from pooled separate accounts	2022-12-31	$-3,778,325
Net investment gain or loss from common/collective trusts	2022-12-31	$-16,118,376
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$10,986,386
Employer contributions (assets) at end of year	2022-12-31	$5,073,538
Employer contributions (assets) at beginning of year	2022-12-31	$3,477,916
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$11,222,345
Contract administrator fees	2022-12-31	$225,231
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	CARON & BLETZER, PLLC
Accountancy firm EIN	2022-12-31	043499945
2021 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$42,536,242
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$14,787,693
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$14,556,504
Value of total corrective distributions	2021-12-31	$2,255
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$18,936,365
Value of total assets at end of year	2021-12-31	$189,388,257
Value of total assets at beginning of year	2021-12-31	$161,639,708
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$228,934
Total interest from all sources	2021-12-31	$63,097
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$369,773
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$369,773
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$8,399,248
Participant contributions at end of year	2021-12-31	$1,983,731
Participant contributions at beginning of year	2021-12-31	$1,214,161
Participant contributions at end of year	2021-12-31	$215,993
Participant contributions at beginning of year	2021-12-31	$195,838
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$1,880,544
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2021-12-31	$222
Other income not declared elsewhere	2021-12-31	$246
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$27,748,549
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$189,388,257
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$161,639,708
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$50,411,979
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$42,134,960
Value of interest in pooled separate accounts at end of year	2021-12-31	$23,489,020
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$25,601,603
Interest on participant loans	2021-12-31	$63,097
Value of interest in common/collective trusts at end of year	2021-12-31	$109,809,618
Value of interest in common/collective trusts at beginning of year	2021-12-31	$87,904,539
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$6,926,409
Net investment gain/loss from pooled separate accounts	2021-12-31	$4,304,927
Net investment gain or loss from common/collective trusts	2021-12-31	$11,935,425
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$8,656,573
Employer contributions (assets) at end of year	2021-12-31	$3,477,916
Employer contributions (assets) at beginning of year	2021-12-31	$4,588,607
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$14,556,282
Contract administrator fees	2021-12-31	$228,934
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	CARON & BLETZER, PLLC
Accountancy firm EIN	2021-12-31	043499945
2020 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$37,167,128
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$10,300,934
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$10,103,082
Expenses. Certain deemed distributions of participant loans	2020-12-31	$0
Value of total corrective distributions	2020-12-31	$1,704
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$17,846,234
Value of total assets at end of year	2020-12-31	$161,639,708
Value of total assets at beginning of year	2020-12-31	$134,773,514
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$196,148
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$21,578
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$332,857
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$332,857
Administrative expenses professional fees incurred	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Amount of non-exempt transactions with any party-in-interest	2020-12-31	$0
Contributions received from participants	2020-12-31	$7,887,493
Participant contributions at end of year	2020-12-31	$1,214,161
Participant contributions at end of year	2020-12-31	$195,838
Participant contributions at beginning of year	2020-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$1,196,734
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$3
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$374
Administrative expenses (other) incurred	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$26,866,194
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$161,639,708
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$134,773,514
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2020-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$42,134,960
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$31,393,938
Value of interest in pooled separate accounts at end of year	2020-12-31	$25,601,603
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$29,017,818
Interest on participant loans	2020-12-31	$21,578
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$0
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest in common/collective trusts at end of year	2020-12-31	$87,904,539
Value of interest in common/collective trusts at beginning of year	2020-12-31	$70,647,836
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$7,681,014
Net investment gain/loss from pooled separate accounts	2020-12-31	$1,657,831
Net investment gain or loss from common/collective trusts	2020-12-31	$9,627,240
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$8,762,007
Employer contributions (assets) at end of year	2020-12-31	$4,588,607
Employer contributions (assets) at beginning of year	2020-12-31	$3,713,922
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$10,103,079
Contract administrator fees	2020-12-31	$196,148
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	CARON AND BLETZER PLLC
Accountancy firm EIN	2020-12-31	043499945
2019 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$625
Total income from all sources (including contributions)	2019-12-31	$37,591,202
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$10,580,016
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$10,377,980
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$15,058,155
Value of total assets at end of year	2019-12-31	$134,773,514
Value of total assets at beginning of year	2019-12-31	$107,762,953
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$202,036
Total interest from all sources	2019-12-31	$22
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$386,850
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$386,850
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$6,734,485
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$1,258
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$889,871
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$6,312,013
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2019-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$625
Other income not declared elsewhere	2019-12-31	$32
Administrative expenses (other) incurred	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$27,011,186
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$134,773,514
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$107,762,328
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$31,393,938
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$2,166,131
Value of interest in pooled separate accounts at end of year	2019-12-31	$29,017,818
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$47,062,993
Interest on participant loans	2019-12-31	$22
Value of interest in common/collective trusts at end of year	2019-12-31	$70,647,836
Value of interest in common/collective trusts at beginning of year	2019-12-31	$48,930,201
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$3,291,888
Net investment gain/loss from pooled separate accounts	2019-12-31	$8,704,965
Net investment gain or loss from common/collective trusts	2019-12-31	$10,149,290
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$7,433,799
Employer contributions (assets) at end of year	2019-12-31	$3,713,922
Employer contributions (assets) at beginning of year	2019-12-31	$3,290,357
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$10,377,980
Contract administrator fees	2019-12-31	$202,036
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CARON & BLETZER, PLLV
Accountancy firm EIN	2019-12-31	043499945
2018 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$6,653,245
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$625
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$450
Total income from all sources (including contributions)	2018-12-31	$5,492,567
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$11,791,607
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$11,783,567
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$12,004,394
Value of total assets at end of year	2018-12-31	$107,762,953
Value of total assets at beginning of year	2018-12-31	$107,408,573
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$8,040
Total interest from all sources	2018-12-31	$94
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$1,491
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$1,491
Administrative expenses professional fees incurred	2018-12-31	$0
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$5,516,160
Participant contributions at end of year	2018-12-31	$1,258
Participant contributions at beginning of year	2018-12-31	$3,345
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$498,250
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$6,312,013
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2018-12-31	$625
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2018-12-31	$450
Administrative expenses (other) incurred	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-6,299,040
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$107,762,328
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$107,408,123
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$2,166,131
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$2,837,944
Value of interest in pooled separate accounts at end of year	2018-12-31	$47,062,993
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$53,693,872
Interest on participant loans	2018-12-31	$94
Value of interest in common/collective trusts at end of year	2018-12-31	$48,930,201
Value of interest in common/collective trusts at beginning of year	2018-12-31	$48,263,763
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-238,816
Net investment gain/loss from pooled separate accounts	2018-12-31	$-3,133,621
Net investment gain or loss from common/collective trusts	2018-12-31	$-3,140,975
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$5,989,984
Employer contributions (assets) at end of year	2018-12-31	$3,290,357
Employer contributions (assets) at beginning of year	2018-12-31	$2,609,649
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$11,783,567
Contract administrator fees	2018-12-31	$8,040
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	MARCUM LLP
Accountancy firm EIN	2018-12-31	111986323
2017 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$0
Total transfer of assets from this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$450
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Expenses. Interest paid	2017-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$25,541,984
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$10,154,120
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$10,146,962
Expenses. Certain deemed distributions of participant loans	2017-12-31	$0
Value of total corrective distributions	2017-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$10,662,207
Value of total assets at end of year	2017-12-31	$107,408,573
Value of total assets at beginning of year	2017-12-31	$92,020,259
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$7,158
Total interest from all sources	2017-12-31	$259
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$3,034
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$3,034
Administrative expenses professional fees incurred	2017-12-31	$0
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$4,785,332
Participant contributions at end of year	2017-12-31	$3,345
Participant contributions at beginning of year	2017-12-31	$7,109
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$534,666
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2017-12-31	$450
Other income not declared elsewhere	2017-12-31	$2,921
Administrative expenses (other) incurred	2017-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Income. Non cash contributions	2017-12-31	$0
Value of net income/loss	2017-12-31	$15,387,864
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$107,408,123
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$92,020,259
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$2,837,944
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$2,221,510
Value of interest in pooled separate accounts at end of year	2017-12-31	$53,693,872
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$50,855,858
Interest on participant loans	2017-12-31	$259
Value of interest in common/collective trusts at end of year	2017-12-31	$48,263,763
Value of interest in common/collective trusts at beginning of year	2017-12-31	$36,112,034
Expenses. Payments to insurance carriers foe the provision of benefits	2017-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$540,808
Net investment gain/loss from pooled separate accounts	2017-12-31	$8,804,245
Net investment gain or loss from common/collective trusts	2017-12-31	$5,528,510
Net gain/loss from 103.12 investment entities	2017-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$5,342,209
Employer contributions (assets) at end of year	2017-12-31	$2,609,649
Employer contributions (assets) at beginning of year	2017-12-31	$2,823,748
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$10,146,962
Contract administrator fees	2017-12-31	$7,158
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	MARCUM LLP
Accountancy firm EIN	2017-12-31	111986323
2016 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Expenses. Interest paid	2016-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$18,088,472
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$7,824,923
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$7,813,229
Expenses. Certain deemed distributions of participant loans	2016-12-31	$0
Value of total corrective distributions	2016-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$11,488,033
Value of total assets at end of year	2016-12-31	$92,020,259
Value of total assets at beginning of year	2016-12-31	$81,756,710
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$11,694
Total interest from all sources	2016-12-31	$530
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$1,823
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$1,823
Administrative expenses professional fees incurred	2016-12-31	$0
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$4,781,751
Participant contributions at end of year	2016-12-31	$7,109
Participant contributions at beginning of year	2016-12-31	$11,252
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$1,176,284
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2016-12-31	$0
Other income not declared elsewhere	2016-12-31	$0
Administrative expenses (other) incurred	2016-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Income. Non cash contributions	2016-12-31	$0
Value of net income/loss	2016-12-31	$10,263,549
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$92,020,259
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$81,756,710
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$2,221,510
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$3,831,236
Value of interest in pooled separate accounts at end of year	2016-12-31	$50,855,858
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$67,844,772
Interest on participant loans	2016-12-31	$530
Value of interest in common/collective trusts at end of year	2016-12-31	$36,112,034
Value of interest in common/collective trusts at beginning of year	2016-12-31	$7,604,383
Expenses. Payments to insurance carriers foe the provision of benefits	2016-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$276,434
Net investment gain/loss from pooled separate accounts	2016-12-31	$5,158,209
Net investment gain or loss from common/collective trusts	2016-12-31	$1,163,443
Net gain/loss from 103.12 investment entities	2016-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$5,529,998
Employer contributions (assets) at end of year	2016-12-31	$2,823,748
Employer contributions (assets) at beginning of year	2016-12-31	$2,465,067
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$7,813,229
Contract administrator fees	2016-12-31	$11,694
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	MARCUM LLP
Accountancy firm EIN	2016-12-31	111986323
2015 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets to this plan	2015-12-31	$0
Total transfer of assets from this plan	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Expenses. Interest paid	2015-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$9,164,115
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$8,133,880
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$8,123,844
Expenses. Certain deemed distributions of participant loans	2015-12-31	$549
Value of total corrective distributions	2015-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$8,537,162
Value of total assets at end of year	2015-12-31	$81,756,710
Value of total assets at beginning of year	2015-12-31	$80,726,475
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$9,487
Total interest from all sources	2015-12-31	$1,007
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$15,297
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$15,297
Administrative expenses professional fees incurred	2015-12-31	$0
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$3,759,039
Participant contributions at end of year	2015-12-31	$11,252
Participant contributions at beginning of year	2015-12-31	$32,664
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$310,395
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2015-12-31	$0
Other income not declared elsewhere	2015-12-31	$0
Administrative expenses (other) incurred	2015-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$1,030,235
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$81,756,710
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$80,726,475
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$3,831,236
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$4,595,942
Value of interest in pooled separate accounts at end of year	2015-12-31	$67,844,772
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$66,817,971
Income. Interest from loans (other than to participants)	2015-12-31	$1,007
Value of interest in common/collective trusts at end of year	2015-12-31	$7,604,383
Value of interest in common/collective trusts at beginning of year	2015-12-31	$7,328,310
Expenses. Payments to insurance carriers foe the provision of benefits	2015-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-438,781
Net investment gain/loss from pooled separate accounts	2015-12-31	$979,554
Net investment gain or loss from common/collective trusts	2015-12-31	$69,876
Net gain/loss from 103.12 investment entities	2015-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$4,467,728
Employer contributions (assets) at end of year	2015-12-31	$2,465,067
Employer contributions (assets) at beginning of year	2015-12-31	$1,951,588
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$8,123,844
Contract administrator fees	2015-12-31	$9,487
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	MARCUM LLP
Accountancy firm EIN	2015-12-31	111986323
2014 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets to this plan	2014-12-31	$0
Total transfer of assets from this plan	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Expenses. Interest paid	2014-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$11,624,178
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$4,908,779
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$4,896,702
Expenses. Certain deemed distributions of participant loans	2014-12-31	$771
Value of total corrective distributions	2014-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$7,237,138
Value of total assets at end of year	2014-12-31	$80,726,475
Value of total assets at beginning of year	2014-12-31	$74,011,076
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$11,306
Total interest from all sources	2014-12-31	$3,069
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$12,455
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$12,455
Administrative expenses professional fees incurred	2014-12-31	$0
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$3,337,178
Participant contributions at end of year	2014-12-31	$32,664
Participant contributions at beginning of year	2014-12-31	$100,247
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$268,553
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2014-12-31	$0
Administrative expenses (other) incurred	2014-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$6,715,399
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$80,726,475
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$74,011,076
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Investment advisory and management fees	2014-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$4,595,942
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$4,658,607
Value of interest in pooled separate accounts at end of year	2014-12-31	$66,817,971
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$61,136,579
Interest on participant loans	2014-12-31	$3,069
Value of interest in common/collective trusts at end of year	2014-12-31	$7,328,310
Value of interest in common/collective trusts at beginning of year	2014-12-31	$6,181,632
Expenses. Payments to insurance carriers foe the provision of benefits	2014-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-20,395
Net investment gain/loss from pooled separate accounts	2014-12-31	$4,338,906
Net investment gain or loss from common/collective trusts	2014-12-31	$53,005
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$3,631,407
Employer contributions (assets) at end of year	2014-12-31	$1,951,588
Employer contributions (assets) at beginning of year	2014-12-31	$1,934,011
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$4,896,702
Contract administrator fees	2014-12-31	$11,306
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	MARCUM LLP
Accountancy firm EIN	2014-12-31	111986323
2013 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2013 401k financial data
Total income from all sources (including contributions)	2013-12-31	$19,762,923
Total of all expenses incurred	2013-12-31	$5,467,785
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$5,460,227
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$7,254,620
Value of total assets at end of year	2013-12-31	$74,011,076
Value of total assets at beginning of year	2013-12-31	$59,715,938
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$7,558
Total interest from all sources	2013-12-31	$6,624
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$19,438
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$19,438
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$3,095,754
Participant contributions at end of year	2013-12-31	$100,247
Participant contributions at beginning of year	2013-12-31	$194,645
Participant contributions at beginning of year	2013-12-31	$2,155
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$703,604
Other income not declared elsewhere	2013-12-31	$7,867
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$14,295,138
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$74,011,076
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$59,715,938
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$4,658,607
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$6,096,326
Value of interest in pooled separate accounts at end of year	2013-12-31	$61,136,579
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$44,677,428
Interest on participant loans	2013-12-31	$6,624
Value of interest in common/collective trusts at end of year	2013-12-31	$6,181,632
Value of interest in common/collective trusts at beginning of year	2013-12-31	$6,832,362
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$1,002,610
Net investment gain/loss from pooled separate accounts	2013-12-31	$11,416,375
Net investment gain or loss from common/collective trusts	2013-12-31	$55,389
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$3,455,262
Employer contributions (assets) at end of year	2013-12-31	$1,934,011
Employer contributions (assets) at beginning of year	2013-12-31	$1,913,022
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$5,460,227
Contract administrator fees	2013-12-31	$7,558
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	MARCUM LLP
Accountancy firm EIN	2013-12-31	111986323
2012 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2012 401k financial data
Total income from all sources (including contributions)	2012-12-31	$14,232,906
Total of all expenses incurred	2012-12-31	$3,581,625
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$3,570,083
Expenses. Certain deemed distributions of participant loans	2012-12-31	$8,382
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$8,065,321
Value of total assets at end of year	2012-12-31	$59,715,938
Value of total assets at beginning of year	2012-12-31	$49,064,657
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$3,160
Total interest from all sources	2012-12-31	$12,552
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$59,919
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$59,919
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$3,728,662
Participant contributions at end of year	2012-12-31	$194,645
Participant contributions at beginning of year	2012-12-31	$345,462
Participant contributions at end of year	2012-12-31	$2,155
Participant contributions at beginning of year	2012-12-31	$94,109
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$460,157
Other income not declared elsewhere	2012-12-31	$1,778
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$10,651,281
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$59,715,938
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$49,064,657
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$6,096,326
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$4,651,500
Value of interest in pooled separate accounts at end of year	2012-12-31	$44,677,428
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$35,107,500
Interest on participant loans	2012-12-31	$12,552
Value of interest in common/collective trusts at end of year	2012-12-31	$6,832,362
Value of interest in common/collective trusts at beginning of year	2012-12-31	$6,731,959
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$584,576
Net investment gain/loss from pooled separate accounts	2012-12-31	$5,425,214
Net investment gain or loss from common/collective trusts	2012-12-31	$83,546
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$3,876,502
Employer contributions (assets) at end of year	2012-12-31	$1,913,022
Employer contributions (assets) at beginning of year	2012-12-31	$2,134,127
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$3,570,083
Contract administrator fees	2012-12-31	$3,160
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	MARCUM LLP
Accountancy firm EIN	2012-12-31	111986323
2011 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2011 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total income from all sources (including contributions)	2011-12-31	$7,504,792
Total of all expenses incurred	2011-12-31	$2,595,692
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$2,560,279
Expenses. Certain deemed distributions of participant loans	2011-12-31	$32,100
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$8,158,204
Value of total assets at end of year	2011-12-31	$49,064,657
Value of total assets at beginning of year	2011-12-31	$44,155,557
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$3,313
Total interest from all sources	2011-12-31	$22,215
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$42,919
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$42,919
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$3,574,350
Participant contributions at end of year	2011-12-31	$345,462
Participant contributions at beginning of year	2011-12-31	$572,451
Participant contributions at end of year	2011-12-31	$94,109
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$1,479,874
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$4,909,100
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$49,064,657
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$44,155,557
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$4,651,500
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$4,675,039
Value of interest in pooled separate accounts at end of year	2011-12-31	$35,107,500
Value of interest in pooled separate accounts at beginning of year	2011-12-31	$33,191,689
Interest on participant loans	2011-12-31	$22,215
Value of interest in common/collective trusts at end of year	2011-12-31	$6,731,959
Value of interest in common/collective trusts at beginning of year	2011-12-31	$5,716,378
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-481,540
Net investment gain/loss from pooled separate accounts	2011-12-31	$-339,945
Net investment gain or loss from common/collective trusts	2011-12-31	$102,939
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$3,103,980
Employer contributions (assets) at end of year	2011-12-31	$2,134,127
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$2,560,279
Contract administrator fees	2011-12-31	$3,313
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	MARCUM LLP
Accountancy firm EIN	2011-12-31	111986323
2010 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$10,914,579
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$1,998,079
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$1,993,383
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$5,197,500
Value of total assets at end of year	2010-12-31	$44,155,557
Value of total assets at beginning of year	2010-12-31	$35,239,057
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$4,696
Total interest from all sources	2010-12-31	$28,080
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$8,243
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$8,243
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$2,186,052
Participant contributions at end of year	2010-12-31	$572,451
Participant contributions at beginning of year	2010-12-31	$488,438
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$14,615
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2010-12-31	$10
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$8,916,500
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$44,155,557
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$35,239,057
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$4,675,039
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$1,194,769
Value of interest in pooled separate accounts at end of year	2010-12-31	$33,191,689
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$28,506,138
Interest on participant loans	2010-12-31	$28,080
Value of interest in common/collective trusts at end of year	2010-12-31	$5,716,378
Value of interest in common/collective trusts at beginning of year	2010-12-31	$5,049,712
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$472,153
Net investment gain/loss from pooled separate accounts	2010-12-31	$5,095,375
Net investment gain or loss from common/collective trusts	2010-12-31	$113,228
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$2,996,833
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$1,993,373
Contract administrator fees	2010-12-31	$4,696
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	MARCUM LLP
Accountancy firm EIN	2010-12-31	111986323
2009 : LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN

2022: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	Yes
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	Yes
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2018: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2017: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2016: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2015: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2014: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2013: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2012: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2011: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Insurance	Yes
2011-01-01	Plan benefit arrangement – Insurance	Yes
2010: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Insurance	Yes
2010-01-01	Plan benefit arrangement – Insurance	Yes
2009: LUITPOLD PHARMACEUTICALS, INC. 401(K) AND PROFIT SHARING PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Insurance	Yes
2009-01-01	Plan benefit arrangement – Insurance	Yes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

800566

Policy instance

Insurance contract or identification number	800566
Number of Individuals Covered	1675
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

800566

Policy instance

Insurance contract or identification number	800566
Number of Individuals Covered	1519
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

800566

Policy instance

Insurance contract or identification number	800566
Number of Individuals Covered	1505
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $2,529
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $0
Amount paid for insurance broker fees	1384
Additional information about fees paid to insurance broker	REFERRAL/SERVICE FEE
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

8-00566

Policy instance

Insurance contract or identification number	8-00566
Number of Individuals Covered	1454
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $9,600
Amount paid for insurance broker fees	9600
Additional information about fees paid to insurance broker	REFERRAL / SERVICE FEE
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

8-00566

Policy instance

Insurance contract or identification number	8-00566
Number of Individuals Covered	1235
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $58,984
Total amount of fees paid to insurance company	USD $12,506
Commission paid to Insurance Broker	USD $58,984
Insurance broker organization code?	3
Amount paid for insurance broker fees	12506
Additional information about fees paid to insurance broker	REFERRAL / SERVICE FEE

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

8-00566

Policy instance

Insurance contract or identification number	8-00566
Number of Individuals Covered	1138
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Total amount of commissions paid to insurance broker	USD $58,150
Total amount of fees paid to insurance company	USD $24,377
Commission paid to Insurance Broker	USD $58,150
Amount paid for insurance broker fees	10808
Additional information about fees paid to insurance broker	REFERRAL / SERVICE FEE
Insurance broker organization code?	3
Insurance broker name	PROFESSIONAL PENSION PLANNERS, INC.

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	AMERICAN REGENT, INC.
Employer identification number (EIN):	112695700
NAIC Classification:	325410

Jurisdiction of Incorporation:	New York Department of State
Incorporation Date:	1946-04-02
Company Identification Number:	58306
Legal Registered Office Address:	5 Ramsey Road 5 RAMSEY ROAD Shirley United States of America (USA) 11967